David (Scott) Wilson

Scott in an Assistant Professor in Biomedical Engineering at Johns Hopkins University. Scott’s research focuses on the synthesis and preclinical validation of biomaterials-based immunomodulatory therapies that bias the adaptive immune response towards immunity or tolerance.  Utilizing organic chemistry, the aim of Scott’s group is to synthesize bespoke biomaterials with specific immunomodulatory functionalities. In particular, Scott is interested in the development of immunity-inducing therapies for the treatment of malignancy and infectious disease as well as tolerance-induction strategies that knock out the antigen-specific immune responses driving autoimmunity, transplant rejections, and the immunogenicity of protein-based therapeutics. In addition to immunomodulatory therapies, Scott’s lab is also interested in platforms that modulate the spatial-temporal delivery of both small molecules and biologics.